Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism

Abstract

Simple polyglutamine (polyQ) peptides aggregate in vitro via a nucleated growth pathway directly yielding amyloid-like aggregates. We show here that the 17-amino-acid flanking sequence (HTTNT) N-terminal to the polyQ in the toxic huntingtin exon 1 fragment imparts onto this peptide a complex alternative aggregation mechanism. In isolation, the HTTNT peptide is a compact coil that resists aggregation. When polyQ is fused to this sequence, it induces in HTTNT, in a repeat-length dependent fashion, a more extended conformation that greatly enhances its aggregation into globular oligomers with HTTNT cores and exposed polyQ. In a second step, a new, amyloid-like aggregate is formed with a core composed of both HTTNT and polyQ. The results indicate unprecedented complexity in how primary sequence controls aggregation within a substantially disordered peptide and have implications for the molecular mechanism of Huntington's disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Aggregation kinetics of huntingtin exon 1 mimic peptides exploring various polyQ repeat lengths.
Figure 2: Electron micrographs of various HTTNT-related aggregates.
Figure 3: State of expansion of the HTTNT peptide in solution.
Figure 4: Concentration-dependent CD spectra of HTTNT.
Figure 5: Proton NMR analysis of HTTNT.
Figure 6: PONDR analysis of the first 600 amino acids of the human huntingtin sequence.
Figure 7: Time course of aggregation of HTTNTQ30P6 (F17W) by multiple analyses.
Figure 8: Time course of aggregation of HTTNTQ20P10 by multiple analyses.
Figure 9: Mechanism of HTTNT-mediated exon 1 aggregation.

Similar content being viewed by others

References

  1. Bates, G.P. & Benn, C. The polyglutamine diseases. in Huntington's Disease (eds. Bates, G.P., Harper, P.S. & Jones, L.) 429–472 (Oxford University Press, Oxford, 2002).

  2. Andreson, J.M. et al. The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Ann. Hum. Genet. 71, 295–301 (2007).

    Article  Google Scholar 

  3. Wetzel, R. Misfolding and aggregation in Huntington's disease and other expanded polyglutamine repeat diseases. in Protein Misfolding Diseases: Current and Emerging Principles and Therapies (eds. Dobson, C.M., Kelly, J.W. & Ramirez-Alvarado, M.) (Wiley, New York, in the press).

  4. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805–810 (2004).

    Article  CAS  Google Scholar 

  5. Chen, S., Ferrone, F. & Wetzel, R. Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA 99, 11884–11889 (2002).

    Article  CAS  Google Scholar 

  6. Bhattacharyya, A.M., Thakur, A.K. & Wetzel, R. Polyglutamine aggregation nucleation: thermodynamics of a highly unfavorable protein folding reaction. Proc. Natl. Acad. Sci. USA 102, 15400–15405 (2005).

    Article  CAS  Google Scholar 

  7. Wetzel, R. Chemical and physical properties of polyglutamine repeat sequences. in Genetic Instabilities and Neurological Diseases (eds. Wells, R.D. & Ashizawa, T.) 517–534 (Elsevier, San Diego, 2006).

    Chapter  Google Scholar 

  8. Slepko, N. et al. Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins. Proc. Natl. Acad. Sci. USA 103, 14367–14372 (2006).

    Article  CAS  Google Scholar 

  9. Scherzinger, E. et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549–558 (1997).

    Article  CAS  Google Scholar 

  10. Poirier, M.A. et al. Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J. Biol. Chem. 277, 41032–41037 (2002).

    Article  CAS  Google Scholar 

  11. Wacker, J.L., Zareie, M.H., Fong, H., Sarikaya, M. & Muchowski, P.J. Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat. Struct. Mol. Biol. 11, 1215–1222 (2004).

    Article  CAS  Google Scholar 

  12. Caughey, B. & Lansbury, P.T. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26, 267–298 (2003).

    Article  CAS  Google Scholar 

  13. Graham, R.K. et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125, 1179–1191 (2006).

    Article  CAS  Google Scholar 

  14. Bhattacharyya, A. et al. Oligoproline effects on polyglutamine conformation and aggregation. J. Mol. Biol. 355, 524–535 (2006).

    Article  CAS  Google Scholar 

  15. Dyson, H.J. & Wright, P.E. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6, 197–208 (2005).

    Article  CAS  Google Scholar 

  16. Masino, L. et al. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. J. Mol. Biol. 344, 1021–1035 (2004).

    Article  CAS  Google Scholar 

  17. de Chiara, C., Menon, R.P., Dal Piaz, F., Calder, L. & Pastore, A. Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein. J. Mol. Biol. 354, 883–893 (2005).

    Article  CAS  Google Scholar 

  18. Bulone, D., Masino, L., Thomas, D.J., San Biagio, P.L. & Pastore, A. The innterplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils. PLoS ONE 1, e111 (2006).

    Article  Google Scholar 

  19. Ellisdon, A.M., Thomas, B. & Bottomley, S.P. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step. J. Biol. Chem. 281, 16888–16896 (2006).

    Article  CAS  Google Scholar 

  20. Ignatova, Z. & Gierasch, L.M. Extended polyglutamine tracts cause aggregation and structural perturbation of an adjacent β-barrel protein. J. Biol. Chem. 281, 12959–12967 (2006).

    Article  CAS  Google Scholar 

  21. Ignatova, Z., Thakur, A.K., Wetzel, R. & Gierasch, L.M. In-cell aggregation of a polyglutamine-containing chimera is a multistep process initiated by the flanking sequence. J. Biol. Chem. 282, 36736–36743 (2007).

    Article  CAS  Google Scholar 

  22. Duennwald, M.L., Jagadish, S., Muchowski, P.J. & Lindquist, S. Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc. Natl. Acad. Sci. USA 103, 11045–11050 (2006).

    Article  CAS  Google Scholar 

  23. Rockabrand, E. et al. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum. Mol. Genet. 16, 61–77 (2007).

    Article  CAS  Google Scholar 

  24. O'Nuallain, B. et al. Kinetics and thermodynamics of amyloid assembly using a high-performance liquid chromatography-based sedimentation assay. Methods Enzymol. 413, 34–74 (2006).

    Article  CAS  Google Scholar 

  25. Chen, S., Berthelier, V., Yang, W. & Wetzel, R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311, 173–182 (2001).

    Article  CAS  Google Scholar 

  26. Ferrone, F. Analysis of protein aggregation kinetics. Methods Enzymol. 309, 256–274 (1999).

    Article  CAS  Google Scholar 

  27. Modler, A.J. et al. Polymerization of proteins into amyloid protofibrils shares common critical oligomeric states but differs in the mechanisms of their formation. Amyloid 11, 215–231 (2004).

    Article  CAS  Google Scholar 

  28. Bieschke, J. et al. Small molecule oxidation products trigger disease-associated protein misfolding. Acc. Chem. Res. 39, 611–619 (2006).

    Article  CAS  Google Scholar 

  29. Rousseau, F., Schymkowitz, J. & Serrano, L. Protein aggregation and amyloidosis: confusion of the kinds? Curr. Opin. Struct. Biol. 16, 118–126 (2006).

    Article  CAS  Google Scholar 

  30. Wetzel, R. Mutations and off-pathway aggregation. Trends Biotechnol. 12, 193–198 (1994).

    Article  CAS  Google Scholar 

  31. Marqusee, S., Robbins, V.H. & Baldwin, R.L. Unusually stable helix formation in short alanine-based peptides. Proc. Natl. Acad. Sci. USA 86, 5286–5290 (1989).

    Article  CAS  Google Scholar 

  32. Schuler, B., Lipman, E.A. & Eaton, W.A. Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy. Nature 419, 743–747 (2002).

    Article  CAS  Google Scholar 

  33. Wu, P. & Brand, L. Resonance energy transfer: methods and applications. Anal. Biochem. 218, 1–13 (1994).

    Article  CAS  Google Scholar 

  34. Fitzkee, N.C. & Rose, G.D. Reassessing random-coil statistics in unfolded proteins. Proc. Natl. Acad. Sci. USA 101, 12497–12502 (2004).

    Article  CAS  Google Scholar 

  35. Atwal, R.S. et al. Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet. 16, 2600–2615 (2007).

    Article  CAS  Google Scholar 

  36. Whitmore, L. & Wallace, B.A. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 32, W668–W673 (2004).

    Article  CAS  Google Scholar 

  37. Mohan, A. et al. Analysis of molecular recognition features (MoRFs). J. Mol. Biol. 362, 1043–1059 (2006).

    Article  CAS  Google Scholar 

  38. LeVine, H. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274–284 (1999).

    Article  CAS  Google Scholar 

  39. O'Nuallain, B., Williams, A.D., Westermark, P. & Wetzel, R. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 279, 17490–17499 (2004).

    Article  CAS  Google Scholar 

  40. Serio, T.R. et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317–1321 (2000).

    Article  CAS  Google Scholar 

  41. Kodali, R. & Wetzel, R. Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. Struct. Biol. 17, 48–57 (2007).

    Article  CAS  Google Scholar 

  42. Bevivino, A.E. & Loll, P.J. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel β-fibrils. Proc. Natl. Acad. Sci. USA 98, 11955–11960 (2001).

    Article  CAS  Google Scholar 

  43. Bracken, C., Iakoucheva, L.M., Romero, P.R. & Dunker, A.K. Combining prediction, computation and experiment for the characterization of protein disorder. Curr. Opin. Struct. Biol. 14, 570–576 (2004).

    Article  CAS  Google Scholar 

  44. Hammarstrom, P. et al. Structural mapping of an aggregation nucleation site in a molten globule intermediate. J. Biol. Chem. 274, 32897–32903 (1999).

    Article  CAS  Google Scholar 

  45. Cattaneo, E. et al. Loss of normal huntingtin function: new developments in Huntington's disease research. Trends Neurosci. 24, 182–188 (2001).

    Article  CAS  Google Scholar 

  46. Kaltenbach, L.S. et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3, e82 (2007).

    Article  Google Scholar 

  47. Nozaki, K., Onodera, O., Takano, H. & Tsuji, S. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation. Neuroreport 12, 3357–3364 (2001).

    Article  CAS  Google Scholar 

  48. Steffan, J.S. et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100–104 (2004).

    Article  CAS  Google Scholar 

  49. Colby, D.W. et al. Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. Proc. Natl. Acad. Sci. USA 101, 17616–17621 (2004).

    Article  CAS  Google Scholar 

  50. Wanderer, J. & Morton, A.J. Differential morphology and composition of inclusions in the R6/2 mouse and PC12 cell models of Huntington's disease. Histochem. Cell Biol. 127, 473–484 (2007).

    Article  CAS  Google Scholar 

  51. Chen, S., Berthelier, V., Hamilton, J.B., O'Nuallain, B. & Wetzel, R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41, 7391–7399 (2002).

    Article  CAS  Google Scholar 

  52. Liu, M. et al. Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy. J. Magn. Reson. 132, 125–129 (1998).

    Article  CAS  Google Scholar 

  53. Bax, A. & Davis, D.G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355–360 (1985).

    CAS  Google Scholar 

  54. Schwarzinger, S. et al. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123, 2970–2978 (2001).

    Article  CAS  Google Scholar 

  55. Lakowicz, J.R. Principles of Fluoresence Spectroscopy 954 (Kluwer, New York, 2006).

    Book  Google Scholar 

  56. Tcherkasskaya, O. & Ptitsyn, O.B. Direct energy transfer to study the 3D structure of non-native proteins: AGH complex in molten globule state of apomyoglobin. Protein Eng. 12, 485–490 (1999).

    Article  CAS  Google Scholar 

  57. Ko, J., Ou, S. & Patterson, P.H. New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Brain Res. Bull. 56, 319–329 (2001).

    Article  CAS  Google Scholar 

  58. Sreerama, N. & Woody, R.W. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 287, 252–260 (2000).

    Article  CAS  Google Scholar 

  59. Jackson, M. & Mantsch, H.H. The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit. Rev. Biochem. Mol. Biol. 30, 95–120 (1995).

    Article  CAS  Google Scholar 

  60. Venyaminov, S. & Kalnin, N.N. Quantitative IR spectrophotometry of peptide compounds in water (H2O) solutions. I. Spectral parameters of amino acid residue absorption bands. Biopolymers 30, 1243–1257 (1990).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge J. Ko and P. Patterson (California Institute of Technology) for the gift of the MW1 antibody, and T. Fullam (Allegheny College) for providing a set of aggregation kinetics data. We also acknowledge the following funding sources that contributed to the work described here: NIH R01 AG019322 (R.W.); Huntington's Disease Society of America postdoctoral fellowship (V.M.C.); NSF MCB-0444049 (T.P.C.); Petroleum Research Fund/American Chemical Society 43138-AC4 (T.P.C.); grant #4100026429 from the Commonwealth of Pennsylvania (A.M.G.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronald Wetzel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thakur, A., Jayaraman, M., Mishra, R. et al. Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol 16, 380–389 (2009). https://doi.org/10.1038/nsmb.1570

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nsmb.1570

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing